Global Pneumonia Vaccine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
September 2018
124
About the Report
About the Report
Pneumonia is a lung infection that occurs in one or both the lungs caused by bacteria, viruses, or fungi; however, bacterial pneumonia is the most common form occurring in adults. Center for Disease Control and Prevention (CDC) recommends administration of two pneumococcal vaccines.
Scope of the Report:
This report focuses on the Pneumonia Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Pneumonia Vaccine is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million USD in 2023, from xx million USD in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Market Segment by Applications, can be divided into
Pneumonia
Meningitis
Sepsis
There are 15 Chapters to deeply display the global Pneumonia Vaccine market.
Chapter 1, to describe Pneumonia Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Pneumonia Vaccine, with sales, revenue, and price of Pneumonia Vaccine, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Pneumonia Vaccine, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Pneumonia Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Pneumonia Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Products
Companies
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Table of Contents
Table of Contents
Table of Contents
1 Market Overview
1.1 Pneumonia Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Pneumococcal Conjugate Vaccine (PCV13)
1.2.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.3 Market Analysis by Applications
1.3.1 Pneumonia
1.3.2 Meningitis
1.3.3 Sepsis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Business Overview
2.1.2 Pneumonia Vaccine Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Glaxosmithkline Plc.
2.2.1 Business Overview
2.2.2 Pneumonia Vaccine Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck & Co., Inc.
2.3.1 Business Overview
2.3.2 Pneumonia Vaccine Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sanofi Pasteur
2.4.1 Business Overview
2.4.2 Pneumonia Vaccine Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Serum Institute of India Pvt. Ltd.
2.5.1 Business Overview
2.5.2 Pneumonia Vaccine Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Pneumonia Vaccine Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Astellas Pharma Inc.
2.7.1 Business Overview
2.7.2 Pneumonia Vaccine Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Astrazeneca Plc.
2.8.1 Business Overview
2.8.2 Pneumonia Vaccine Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSL Limited
2.9.1 Business Overview
2.9.2 Pneumonia Vaccine Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Emergent Biosolutions
2.10.1 Business Overview
2.10.2 Pneumonia Vaccine Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Pneumonia Vaccine Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Pneumonia Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Pneumonia Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Pneumonia Vaccine Manufacturer Market Share in 2017
3.3.2 Top 6 Pneumonia Vaccine Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Pneumonia Vaccine Market Analysis by Regions
4.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Pneumonia Vaccine Sales and Market Share by Regions (2013-2018)
4.1.2 Global Pneumonia Vaccine Revenue and Market Share by Regions (2013-2018)
4.2 North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)
4.3 Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)
4.5 South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)
5 North America Pneumonia Vaccine by Countries
5.1 North America Pneumonia Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)
5.1.2 North America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)
5.2 United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)
5.3 Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)
5.4 Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)
6 Europe Pneumonia Vaccine by Countries
6.1 Europe Pneumonia Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)
6.2 Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)
6.3 UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)
6.4 France Pneumonia Vaccine Sales and Growth Rate (2013-2018)
6.5 Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
6.6 Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)
7 Asia-Pacific Pneumonia Vaccine by Countries
7.1 Asia-Pacific Pneumonia Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)
7.2 China Pneumonia Vaccine Sales and Growth Rate (2013-2018)
7.3 Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)
7.4 Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)
7.5 India Pneumonia Vaccine Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
8 South America Pneumonia Vaccine by Countries
8.1 South America Pneumonia Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)
8.1.2 South America Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)
8.3 Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)
8.4 Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
9 Middle East and Africa Pneumonia Vaccine by Countries
9.1 Middle East and Africa Pneumonia Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Pneumonia Vaccine Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Pneumonia Vaccine Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
9.3 UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)
9.4 Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)
9.5 Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)
9.6 South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)
10 Global Pneumonia Vaccine Market Segment by Type
10.1 Global Pneumonia Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Pneumonia Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global Pneumonia Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Pneumococcal Conjugate Vaccine (PCV13) Sales Growth and Price
10.2.1 Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)
10.2.2 Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)
10.3 Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth and Price
10.3.1 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)
10.3.2 Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)
11 Global Pneumonia Vaccine Market Segment by Application
11.1 Global Pneumonia Vaccine Sales Market Share by Application (2013-2018)
11.2 Pneumonia Sales Growth (2013-2018)
11.3 Meningitis Sales Growth (2013-2018)
11.4 Sepsis Sales Growth (2013-2018)
12 Pneumonia Vaccine Market Forecast (2018-2023)
12.1 Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 Pneumonia Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America Pneumonia Vaccine Market Forecast (2018-2023)
12.2.2 Europe Pneumonia Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific Pneumonia Vaccine Market Forecast (2018-2023)
12.2.4 South America Pneumonia Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa Pneumonia Vaccine Market Forecast (2018-2023)
12.3 Pneumonia Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)
12.4 Pneumonia Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Table
List of Tables and Figures
Figure Pneumonia Vaccine Picture
Table Product Specifications of Pneumonia Vaccine
Figure Global Sales Market Share of Pneumonia Vaccine by Types in 2017
Table Pneumonia Vaccine Types for Major Manufacturers
Figure Pneumococcal Conjugate Vaccine (PCV13) Picture
Figure Pneumococcal Polysaccharide Vaccine (PPSV23) Picture
Figure Pneumonia Vaccine Sales Market Share by Applications in 2017
Figure Pneumonia Picture
Figure Meningitis Picture
Figure Sepsis Picture
Figure United States Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure France Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure UK Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure China Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure India Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Pneumonia Vaccine Revenue (Value) and Growth Rate (2013-2023)
Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table Pfizer Inc. Pneumonia Vaccine Type and Applications
Table Pfizer Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Glaxosmithkline Plc. Basic Information, Manufacturing Base and Competitors
Table Glaxosmithkline Plc. Pneumonia Vaccine Type and Applications
Table Glaxosmithkline Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
Table Merck & Co., Inc. Pneumonia Vaccine Type and Applications
Table Merck & Co., Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table Sanofi Pasteur Pneumonia Vaccine Type and Applications
Table Sanofi Pasteur Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Serum Institute of India Pvt. Ltd. Basic Information, Manufacturing Base and Competitors
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Type and Applications
Table Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Pneumonia Vaccine Type and Applications
Table Johnson & Johnson Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table Astellas Pharma Inc. Pneumonia Vaccine Type and Applications
Table Astellas Pharma Inc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Astrazeneca Plc. Basic Information, Manufacturing Base and Competitors
Table Astrazeneca Plc. Pneumonia Vaccine Type and Applications
Table Astrazeneca Plc. Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Limited Basic Information, Manufacturing Base and Competitors
Table CSL Limited Pneumonia Vaccine Type and Applications
Table CSL Limited Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table Emergent Biosolutions Pneumonia Vaccine Type and Applications
Table Emergent Biosolutions Pneumonia Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Pneumonia Vaccine Sales by Manufacturer (2016-2017)
Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2016
Figure Global Pneumonia Vaccine Sales Market Share by Manufacturer in 2017
Table Global Pneumonia Vaccine Revenue by Manufacturer (2016-2017)
Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2016
Figure Global Pneumonia Vaccine Revenue Market Share by Manufacturer in 2017
Figure Top 3 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Pneumonia Vaccine Manufacturer (Revenue) Market Share in 2017
Figure Global Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Global Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table Global Pneumonia Vaccine Sales by Regions (2013-2018)
Table Global Pneumonia Vaccine Sales Market Share by Regions (2013-2018)
Table Global Pneumonia Vaccine Revenue by Regions (2013-2018)
Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2013
Figure Global Pneumonia Vaccine Revenue Market Share by Regions in 2017
Figure North America Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure North America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table North America Pneumonia Vaccine Sales by Countries (2013-2018)
Table North America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)
Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2013
Figure North America Pneumonia Vaccine Sales Market Share by Countries in 2017
Table North America Pneumonia Vaccine Revenue by Countries (2013-2018)
Table North America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)
Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2013
Figure North America Pneumonia Vaccine Revenue Market Share by Countries in 2017
Figure United States Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Canada Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Mexico Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Europe Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table Europe Pneumonia Vaccine Sales by Countries (2013-2018)
Table Europe Pneumonia Vaccine Sales Market Share by Countries (2013-2018)
Table Europe Pneumonia Vaccine Revenue by Countries (2013-2018)
Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2016
Figure Europe Pneumonia Vaccine Revenue Market Share by Countries in 2017
Figure Germany Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure UK Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure France Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Russia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Italy Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Pneumonia Vaccine Sales by Countries (2013-2018)
Table Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Pneumonia Vaccine Sales Market Share by Countries 2017
Table Asia-Pacific Pneumonia Vaccine Revenue by Countries (2013-2018)
Figure Asia-Pacific Pneumonia Vaccine Revenue Market Share by Countries 2017
Figure China Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Japan Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Korea Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure India Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Southeast Asia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure South America Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table South America Pneumonia Vaccine Sales by Countries (2013-2018)
Table South America Pneumonia Vaccine Sales Market Share by Countries (2013-2018)
Figure South America Pneumonia Vaccine Sales Market Share by Countries in 2017
Table South America Pneumonia Vaccine Revenue by Countries (2013-2018)
Table South America Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)
Figure South America Pneumonia Vaccine Revenue Market Share by Countries in 2017
Figure Brazil Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Argentina Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Colombia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Pneumonia Vaccine Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Pneumonia Vaccine Sales by Countries (2013-2018)
Table Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumonia Vaccine Sales Market Share by Countries in 2017
Table Middle East and Africa Pneumonia Vaccine Revenue by Countries (2013-2018)
Table Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2013
Figure Middle East and Africa Pneumonia Vaccine Revenue Market Share by Countries in 2017
Figure Saudi Arabia Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure UAE Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Egypt Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure Nigeria Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Figure South Africa Pneumonia Vaccine Sales and Growth Rate (2013-2018)
Table Global Pneumonia Vaccine Sales by Type (2013-2018)
Table Global Pneumonia Vaccine Sales Share by Type (2013-2018)
Table Global Pneumonia Vaccine Revenue by Type (2013-2018)
Table Global Pneumonia Vaccine Revenue Share by Type (2013-2018)
Figure Global Pneumococcal Conjugate Vaccine (PCV13) Sales Growth (2013-2018)
Figure Global Pneumococcal Conjugate Vaccine (PCV13) Price (2013-2018)
Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Sales Growth (2013-2018)
Figure Global Pneumococcal Polysaccharide Vaccine (PPSV23) Price (2013-2018)
Table Global Pneumonia Vaccine Sales by Application (2013-2018)
Table Global Pneumonia Vaccine Sales Share by Application (2013-2018)
Figure Global Meningitis Sales Growth (2013-2018)
Figure Global Sepsis Sales Growth (2013-2018)
Figure Global Pneumonia Vaccine Sales, Revenue and Growth Rate (2018-2023)
Table Global Pneumonia Vaccine Sales Forecast by Regions (2018-2023)
Table Global Pneumonia Vaccine Market Share Forecast by Regions (2018-2023)
Figure North America Sales Pneumonia Vaccine Market Forecast (2018-2023)
Figure Europe Sales Pneumonia Vaccine Market Forecast (2018-2023)
Figure Asia-Pacific Sales Pneumonia Vaccine Market Forecast (2018-2023)
Figure South America Sales Pneumonia Vaccine Market Forecast (2018-2023)
Figure Middle East and Africa Sales Pneumonia Vaccine Market Forecast (2018-2023)
Table Global Pneumonia Vaccine Sales Forecast by Type (2018-2023)
Table Global Pneumonia Vaccine Market Share Forecast by Type (2018-2023)
Table Global Pneumonia Vaccine Sales Forecast by Application (2018-2023)
Table Global Pneumonia Vaccine Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.